Abstract: A dosing valve is provided for ejecting a liquid from a nozzle outlet channel. The dosing valve has a main body, a valve actuating element movable within the main body, and a valve closure element connected to or actuatable by the valve actuating element. The valve closure element is movable within a dosing chamber between an open position, in which it is lifted off from a nozzle sealing seat, and a closed position, in which it lies against the nozzle sealing seat. For the pneumatic activation of the dosing valve, a switching valve is provided by means of which a working chamber of the dosing valve can be selectively ventilated or charged with a pressurized fluid.

Abstract: A dosing valve is provided for ejecting a liquid from a nozzle outlet channel. The dosing valve has a main body, a valve actuating element movable within the main body, and a valve closure element connected to or actuatable by the valve actuating element. The valve closure element is movable within a dosing chamber between an open position, in which it is lifted off from a nozzle sealing seat, and a closed position, in which it lies against the nozzle sealing seat. For the pneumatic activation of the dosing valve, a switching valve is provided by means of which a working chamber of the dosing valve can be selectively ventilated or charged with a pressurized fluid.

Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.

Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.

Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.

Abstract: A method and a device for segmenting a digital image of biological cells, a method and a device for analyzing the dynamic behavior of biological cells and a method and a device for visualizing the dynamic behavior of biological cells.

Abstract: A method and a device for segmenting a digital image of biological cells, a method and a device for analyzing the dynamic behavior of biological cells and a method and a device for visualizing the dynamic behavior of biological cells.

Abstract: A method and a device for segmenting a digital image of biological cells, a method and a device for analyzing the dynamic behavior of biological cells and a method and a device for visualizing the dynamic behavior of biological cells.

Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.

Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.

Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterized in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombospondin-1 in such a way that the bond between thrombospondin-1 and IAP and/or integrin ?v?3 is inhibited.

Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin ?v?3 is inhibited.

Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.

Abstract: The invention relates to a method and a device for segmenting a digital image (22) of biological cells (2, 3), a method and a device for analyzing the dynamic behavior of biological cells (2, 3) and a method and a device for visualizing the dynamic behavior of biological cells (2, 3).

Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.

Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both IAP and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.

Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.

Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances hond to either IAP and/or integrin &agr;v&bgr;3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin &agr;v&bgr;3 is inhibited.

Abstract: Method and apparatus for sorting waste paper pieces of different grades and conditions. The method includes moving a plurality of waste paper pieces in a conveying direction on at least one sorting belt, each waste paper piece having a surface, irradiating at least one area of the surface with radiation, registering the radiation reflected from the surface, and sorting the waste paper on the basis of the reflected radiation, wherein waste paper pieces of at least one type are separated from waste paper pieces of at least one other type.

Abstract: Electromagnetic body coil for magnetic resonance tomographic measurements, whereby the body coil has a three-dimensional coil shape and is assembled from at least two partial coils which are capable of being brought into a state of detachable plug-in connection with one another by means of an electrical plug-in connection arrangement and whereby a first partial coil is located inside a cushion, that serves as a patient resting aid, and the second partial coil is located outside this cushion.